Effects of Methylphenidate on Quantitative EEG of Boys with Attention-deficit Hyperactivity Disorder in Continuous Performance Test

Overview

Journal Yonsei Med J

Specialty General Medicine

Date 2005 Mar 4

PMID 15744803

Citations 12

Authors

Dong Ho Song

Dong Won Shin

Duk In Jon

Eun Hye Ha

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to investigate the effects of methylphenidate, a psychostimulant, on quantitative electroencephalography (QEEG) during the continuous performance test (CPT) in boys with attention-deficit hyperactivity disorder (ADHD). The QEEG was obtained from 20 boys with ADHD. The amplitudes of 4 bands (alpha, beta, delta, and theta) in the QEEG, as well as the theta /beta ratio, before and after the administration of methylphenidate were compared during both the resting and CPT states. Methylphenidate induced a significant increase of alpha activities in both the right and left frontal and occipital areas, an increase of beta activities in almost all areas except for the temporal region, a decrease of theta activities in both the occipital and right temporo-parietal areas, a mild decrease of delta activities in the occipito-parietal areas, and an increase of the theta/beta ratio in the right frontal and parieto-occipital, and left temporal areas during the CPT state. No significant QEEG changes were induced by the administration of methylphenidate in the resting state. These data suggest that methylphenidate has greater electrophysiological influences on the cerebral topographical activities during the performance of attentional tasks, as compared to the resting state, in boys with ADHD.

Citing Articles

Translating Decades of Neuroscience Research into Diagnostic and Treatment Biomarkers for ADHD.

Loo S, Lenartowicz A, Norman L, Michelini G Adv Neurobiol. 2024; 40:579-616.

PMID: 39562458 DOI: 10.1007/978-3-031-69491-2_20.

Treatment biomarkers for ADHD: Taking stock and moving forward.

Michelini G, Norman L, Shaw P, Loo S Transl Psychiatry. 2022; 12(1):444.

PMID: 36224169 PMC: 9556670. DOI: 10.1038/s41398-022-02207-2.

Target to treatment: A charge to develop biomarkers of response and tolerability in child and adolescent psychiatry.

Stancil S, Tumberger J, Strawn J Clin Transl Sci. 2021; 15(4):816-823.

PMID: 34913258 PMC: 9010264. DOI: 10.1111/cts.13216.

In Quest of Pathognomonic/Endophenotypic Markers of Attention Deficit Hyperactivity Disorder (ADHD): Potential of EEG-Based Frequency Analysis and ERPs to Better Detect, Prevent and Manage ADHD.

Miranda P, Cox C, Alexander M, Danev S, Lakey J Med Devices (Auckl). 2020; 13:115-137.

PMID: 32547262 PMC: 7250294. DOI: 10.2147/MDER.S241205.

Evaluation of Two Types of Drug Treatment with QEEG in Children with ADHD.

Aldemir R, Demirci E, Bayram A, Canpolat M, Ozmen S, Per H Transl Neurosci. 2018; 9:106-116.

PMID: 30191077 PMC: 6124153. DOI: 10.1515/tnsci-2018-0017.

References

Loo S, Specter E, Smolen A, Hopfer C, Teale P, Reite M . Functional effects of the DAT1 polymorphism on EEG measures in ADHD. J Am Acad Child Adolesc Psychiatry. 2003; 42(8):986-93. DOI: 10.1097/01.CHI.0000046890.27264.88. View

Coons H, Klorman R, Borgstedt A . Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: II. Information processing. J Am Acad Child Adolesc Psychiatry. 1987; 26(3):368-74. DOI: 10.1097/00004583-198705000-00016. View

John E, Prichep L, Ahn H, Easton P, Fridman J, Kaye H . Neurometric evaluation of cognitive dysfunctions and neurological disorders in children. Prog Neurobiol. 1983; 21(4):239-90. DOI: 10.1016/0301-0082(83)90014-x. View

Garfinkel B, Brown W, Klee S, BRADEN W, BEAUCHESNE H, SHAPIRO S . Neuroendocrine and cognitive responses to amphetamine in adolescents with a history of attention deficit disorder. J Am Acad Child Psychiatry. 1986; 25(4):503-8. DOI: 10.1016/s0002-7138(10)60009-x. View

Satterfield J, Schell A, Nicholas T, Backs R . Topographic study of auditory event-related potentials in normal boys and boys with attention deficit disorder with hyperactivity. Psychophysiology. 1988; 25(5):591-606. DOI: 10.1111/j.1469-8986.1988.tb01895.x. View

Mitchell W, Chavez J, Baker S, Guzman B, Azen S . Reaction time, impulsivity, and attention in hyperactive children and controls: a video game technique. J Child Neurol. 1990; 5(3):195-204. DOI: 10.1177/088307389000500308. View

Heilman K, Voeller K, Nadeau S . A possible pathophysiologic substrate of attention deficit hyperactivity disorder. J Child Neurol. 1991; 6 Suppl:S76-81. DOI: 10.1177/0883073891006001s09. View

Klorman R, Brumaghim J, Fitzpatrick P, Borgstedt A . Methylphenidate speeds evaluation processes of attention deficit disorder adolescents during a continuous performance test. J Abnorm Child Psychol. 1991; 19(3):263-83. DOI: 10.1007/BF00911231. View

Mann C, LUBAR J, Zimmerman A, Miller C, Muenchen R . Quantitative analysis of EEG in boys with attention-deficit-hyperactivity disorder: controlled study with clinical implications. Pediatr Neurol. 1992; 8(1):30-6. DOI: 10.1016/0887-8994(92)90049-5. View

10.

Voeller K . What can neurological models of attention, intention, and arousal tell us about attention-deficit hyperactivity disorder?. J Neuropsychiatry Clin Neurosci. 1991; 3(2):209-16. DOI: 10.1176/jnp.3.2.209. View

11.

Prichep L, John E . QEEG profiles of psychiatric disorders. Brain Topogr. 1992; 4(4):249-57. DOI: 10.1007/BF01135562. View

12.

John E, Prichep L, Almas M . Subtyping of psychiatric patients by cluster analysis of QEEG. Brain Topogr. 1992; 4(4):321-6. DOI: 10.1007/BF01135569. View

13.

Greenberg L, Waldman I . Developmental normative data on the test of variables of attention (T.O.V.A.). J Child Psychol Psychiatry. 1993; 34(6):1019-30. DOI: 10.1111/j.1469-7610.1993.tb01105.x. View

14.

Corkum P, Siegel L . Is the Continuous Performance Task a valuable research tool for use with children with Attention-Deficit-Hyperactivity Disorder?. J Child Psychol Psychiatry. 1993; 34(7):1217-39. DOI: 10.1111/j.1469-7610.1993.tb01784.x. View

15.

Matochik J, Liebenauer L, King A, Szymanski H, Cohen R, Zametkin A . Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry. 1994; 151(5):658-64. DOI: 10.1176/ajp.151.5.658. View

16.

Verbaten M, Overtoom C, Koelega H, Swaab-Barneveld H, Van der Gaag R, Buitelaar J . Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test. J Abnorm Child Psychol. 1994; 22(5):561-78. DOI: 10.1007/BF02168938. View

17.

Young E, Perros P, Price G, SADLER T . Acute challenge ERP as a prognostic of stimulant therapy outcome in attention-deficit hyperactivity disorder. Biol Psychiatry. 1995; 37(1):25-33. DOI: 10.1016/0006-3223(94)00075-E. View

18.

Carter C, Krener P, Chaderjian M, NORTHCUTT C, Wolfe V . Asymmetrical visual-spatial attentional performance in ADHD: evidence for a right hemispheric deficit. Biol Psychiatry. 1995; 37(11):789-97. DOI: 10.1016/0006-3223(94)00217-Q. View

19.

Kuperman S, Johnson B, Arndt S, Lindgren S, Wolraich M . Quantitative EEG differences in a nonclinical sample of children with ADHD and undifferentiated ADD. J Am Acad Child Adolesc Psychiatry. 1996; 35(8):1009-17. DOI: 10.1097/00004583-199608000-00011. View

20.

Ucles P, Lorente S . Electrophysiologic measures of delayed maturation in attention-deficit hyperactivity disorder. J Child Neurol. 1996; 11(2):155-6. DOI: 10.1177/088307389601100216. View